Abstract |
|
Authors | Noriko Yodoya, Shotaro Iwamoto, Akihiko Matsumine, Eiichi Azuma, Hidemi Toyoda, Yoshihiro Miura, Kaname Nakatani, Hiroshi Imai, Masahiro Hirayama, Yoshihiro Komada |
Journal | Journal of pediatric hematology/oncology
(J Pediatr Hematol Oncol)
Vol. 39
Issue 1
Pg. 6-9
(01 2017)
ISSN: 1536-3678 [Electronic] United States |
PMID | 27918348
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- EWS-FLI fusion protein
- Oncogene Proteins, Fusion
- Proto-Oncogene Protein c-fli-1
- RNA-Binding Protein EWS
- Vincristine
- Etoposide
- Doxorubicin
- Cyclophosphamide
- Carboplatin
- pirarubicin
- Cisplatin
- Ifosfamide
- Methotrexate
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Carboplatin
(administration & dosage, adverse effects)
- Child
- Cisplatin
(administration & dosage, adverse effects)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage)
- Doxorubicin
(administration & dosage, adverse effects, analogs & derivatives)
- Etoposide
(administration & dosage, adverse effects)
- Female
- Femoral Neoplasms
(drug therapy, genetics, surgery)
- Humans
- Ifosfamide
(administration & dosage, adverse effects)
- Limb Salvage
- Methotrexate
(administration & dosage, adverse effects)
- Neoplasms, Second Primary
(drug therapy, genetics, surgery)
- Oncogene Proteins, Fusion
(genetics)
- Osteosarcoma
(drug therapy, surgery)
- Proto-Oncogene Protein c-fli-1
(genetics)
- RNA-Binding Protein EWS
(genetics)
- Remission Induction
- Sarcoma, Ewing
(drug therapy, genetics, surgery)
- Vincristine
(administration & dosage)
|